As communicated in an adhoc press release on Monday June 3rd, during the weekend of 1st/2nd June, Eurofins Scientific (EUFI.PA) was affected by a ransomware attack which caused disruption to many of its IT systems in several countries.

BioMAP profiling is the broadest, most physiologically relevant method to quickly and robustly determine the efficacy, safety, and mechanism of action (MOA) of candidate drug molecules to support their pipeline progression.

Advanced – and expensive – immunotherapies have expanded the arsenal of available treatment options for cancers either resistant or recalcitrant to more common approaches including surgery, radiation, chemotherapy, and hormone therapy.

Excellent Progress in Innovative Drug Discovery Programme with Parkinson’s UK

Analysis shows why failed drug candidates cause adverse skin reactions, and yields biomarker signature to detect problems with future candidates early in preclinical development.

Identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity, published in The Journal of Medicinal Chemistry